NobleGen Biosciences holds exclusive license from Harvard and BU to commercialize breakthrough fourth-generation nanopore sequencing technology. Boston University Professor Amit Meller, an internationally recognized leader in nanopore physics, developed the technology. He has won $8.5 million in NIH funding since 2002. NobleGen is run by Meller and CEO Frank Feist and operates out of UMass Boston’s Venture Development Center.

NobleGen’s technology is designed to be 100x faster than the best projected performance of 3^rd generation sequencing. For more information contact Sean Lee (seanlee@bu.edu).

Boston University professor Raj Mohanty founded Sand9, a company focused on developing high-precision micro-electro-mechanical system (MEMS) technology, in 2007.

The start-up, which spent its early years in OTD’s Technology Incubator, recently revealed the development of MEMS oscillator structures that match the performance of high-end temperature-compensated quartz crystal (TXCO) oscillators. This breakthrough will allow MEMS to compete with TXCO in the mass market for wireless 3/4G cellphones, global positioning systems, and WiFi.

Find out more information about Sand9 on their website or by contacting Sean Lee at OTD (seanlee@bu.edu)